Applications of the present invention relate to transmitting power to an implanted medical device.
Electrical power can be transferred to a percutaneous medical implant by magnetic induction. A current flowing through a coil produces a magnetic field, which, in turn, will induce a current in a second coil, provided the second coil is in close enough proximity to the magnetic field and oriented such that the magnetic field is substantially parallel to the central longitudinal axis of the second coil. A coil inside a medical implant can therefore act as a receiving coil, while a coil outside a patient's body can act as a transmitting coil. A current can be driven through the transmitting coil in order to induce an induced current in the receiving coil, thereby powering the medical implant.
A CBS News article entitled “Migraine ‘smart’ patch tested to help ease pain,” by Steven Reinberg, describes a study performed at Rambam Medical Center in Haifa, Israel, under Dr. David Yarnitzky, chair of neurology at the Rambam Medical Center. The study tested an arm patch to be worn on the upper arm with “[r]ubber electrodes and a chip in the patch [to] produce electric impulses that block pain signals from reaching the brain,” in order to treat migraine pain.
A St. Jude Medical, Inc. fact sheet entitled “Peripheral nerve stimulation for intractable chronic migraine,” describes peripheral nerve stimulation as a treatment for chronic migraines. The fact sheet states that “Peripheral nerve stimulation (PNS) is a therapy that uses mild electrical pulses to stimulate the nerves of the peripheral nervous system. The peripheral nerves make up a network of nerves outside of the central nervous system. For example, the ulnar nerve in the arms and the sciatic nerve in the legs are part of the peripheral nervous system. The St. Jude Medical systems currently approved for PNS in select markets look and operate much like a cardiac pacemaker. However, instead of sending pulses to the heart, the pulses are carried to the occipital nerves, located in the back of the head . . . . Researchers believe that by delivering electrical pulses to these specific peripheral nerve fibers, PNS may influence the way the nerves communicate with the brain and provide an alternative to long-term drug therapy for the relief of chronic migraine.”
A method is described for transmitting power to a medical implant that includes a receiving coil. For some applications, a transmitting coil, disposed in a transmitting coil housing, is placed against skin of a subject such that a central longitudinal axis of the transmitting coil is substantially perpendicular to the skin. For some applications, the medical implant is implanted between an ankle and a knee of a leg of a subject, typically closer to the ankle than the knee. To increase efficiency of the power transfer while accommodating for limited space near the ankle, the transmitting coil is oriented with respect to the skin such that it is not centered over the receiving coil, but rather only a portion of the transmitting coil is disposed directly over the receiving coil. This orientation of the transmitting coil with respect to the receiving coil allows for powering the medical implant using only one transmitting coil. To transmit power to the medical implant, control circuitry is activated to drive a current through the transmitting coil that induces an induced current in the receiving coil.
Typically, the transmitting coil housing and the transmitting coil are flexible in order to comfortably conform to the shape of a limb of the subject. In the absence of any forces applied to the transmitting coil, the transmitting coil has a nominal resonance frequency. In order to accommodate for possible fluctuations in the resonance frequency of the transmitting coil due to the flexing, a sensor may be coupled to the control circuitry and configured to determine an extent of divergence of (a) the resonance frequency of the transmitting coil when the transmitting coil is flexed from (b) the nominal resonance frequency of the transmitting coil, occurring in the absence of any forces applied to the transmitting coil. The control circuitry is further configured to output a signal that controls one or more electrical components that are (a) coupled to the control circuitry and (b) configured to tune the resonance frequency of the transmitting coil in order to compensate for the fluctuations.
There is therefore provided, in accordance with some applications of the present invention, a method for transmitting power to a medical implant that includes a receiving coil that is oriented such that a longitudinal axis of the receiving coil is substantially parallel to skin of a subject, the method including:
providing a transmitting coil disposed in a housing;
placing the housing against the skin such that:
For some applications, placing includes identifying the subject as suffering from migraines or cluster headaches, and in response to the identifying, placing the housing on a leg of a subject such that:
(a) the transmitting coil is disposed between a knee and an angle of the leg, and
(b) the transmitting coil transmits power to a medical implant configured to stimulate a tibial nerve in the leg of the subject.
For some applications, placing includes placing the housing on a leg of the subject such that:
(a) the transmitting coil is disposed between a knee and an ankle of the leg, and
(b) (i) a portion of the transmitting coil that is disposed over the receiving coil is closer to the ankle than (ii) a portion of the transmitting coil that is disposed at 180 degrees from the portion of the transmitting coil that is disposed over the receiving coil, is to the ankle.
For some applications, placing includes placing the housing such that the first distance is 15-45 mm.
For some applications, placing includes placing the housing such that the second distance is less than 30 mm.
For some applications, placing includes placing the housing such that the third distance is 40-60 mm.
For some applications, placing includes placing the housing such that a difference between the third distance and the second distance is 30-40 mm.
For some applications, providing the transmitting coil includes providing a transmitting coil wherein a ratio of (a) a difference between the third distance and the second distance, to (b) a longitudinal length of the receiving coil is greater than 0.5.
For some applications, providing the transmitting coil includes providing a transmitting coil wherein a ratio of (a) a difference between the third distance and the second distance, to (b) a longitudinal length of the receiving coil is less than 1.5.
For some applications, providing the transmitting coil includes providing a transmitting coil wherein a ratio of (a) a difference between the third distance and the second distance, to (b) a longitudinal length of the receiving coil is between 0.5 and 1.5.
For some applications, providing the transmitting coil includes providing a transmitting coil wherein:
(a) a height of the transmitting coil measured along a longitudinal axis of the transmitting coil is 300-600 microns,
(b) an outer diameter of the transmitting coil is 100-140 mm, and
(c) a ratio of the outer diameter of the transmitting coil to the height of the transmitting coil is at least 150.
For some applications, placing includes placing the housing such that the transmitting coil is over a receiving coil, wherein:
(a) a longitudinal length of the receiving coil is 3-15 mm,
(b) an outer diameter of the receiving coil is 0.6-1.5 mm, and
(c) a ratio of the outer diameter of the receiving coil to the longitudinal length of the receiving coil is less than 0.5.
For some applications, activating the control circuitry includes activating the control circuitry to drive the current through the transmitting coil at a frequency of 1-20 MHz.
For some applications, placing includes placing the housing against the skin and subsequently sliding it along the skin until an indicator, coupled to the housing, indicates that the transmitting coil is in an acceptable position with respect to the receiving coil.
For some applications, providing the transmitting coil includes providing a transmitting coil wherein a cross-sectional area of a wire of the transmitting coil is rectangular, wherein the cross-section is taken perpendicular to a direction of current flow within the wire.
For some applications, providing the transmitting coil includes providing a transmitting coil that is elongated in a direction perpendicular to the central longitudinal axis of the receiving coil.
For some applications, providing the transmitting coil includes providing a planar coil disposed in a housing.
For some applications, providing the planar coil includes providing a planar coil including a plurality of layers.
For some applications, providing the planar coil includes providing a planar coil with a line spacing, of adjacent coplanar wires, of 0.25-3 mm.
For some applications, providing the planar coil includes providing a planar coil with a line width of 1-4 mm.
For some applications, providing the transmitting coil includes providing a transmitting coil wherein an average distance from a wire of the transmitting coil to the central longitudinal axis of the transmitting coil is less than two times a square root of a cross-sectional area of a central non-coiled region of the transmitting coil.
For some applications, providing includes providing a transmitting coil wherein an average distance from the wire of the transmitting coil to the central longitudinal axis of the transmitting coil is 0.6-1.5 times the square root of the cross-sectional area of the central non-coiled region of the transmitting coil.
There is further provided, in accordance with some applications of the present invention, apparatus including:
a medical implant, the medical implant including:
a transmitting coil, having wire disposed at all rotational locations about a central longitudinal axis of the transmitting coil, oriented such that:
control circuitry configured to transmit power to the medical implant by driving a current through the transmitting coil that induces an induced current in the receiving coil.
For some applications, the control circuitry is configured to drive the current through the transmitting coil at a frequency of 1-20 MHz.
For some applications, the medical implant is configured to be implanted 1-5 cm below skin of a subject, and the control circuitry is configured to transmit the power, by driving the current through the transmitting coil that induces the induced current in the receiving coil, when the medical implant is implanted 1-5 cm below the skin.
For some applications, the receiving coil is a cylindrical coil including a ferrite core.
For some applications, the first distance is 15-45 mm.
For some applications, the second distance is less than 30 mm.
For some applications, the third distance is 40-60 mm.
For some applications, a difference between the third distance and the second distance is 30-40 mm.
For some applications, a ratio of (a) a difference between the third distance and the second distance, to (b) a longitudinal length of the receiving coil is greater than 0.5.
For some applications, a ratio of (a) a difference between the third distance and the second distance, to (b) a longitudinal length of the receiving coil is less than 1.5.
For some applications, a ratio of (a) a difference between the third distance and the second distance, to (b) a longitudinal length of the receiving coil is between 0.5 and 1.5.
For some applications:
(a) a height of the transmitting coil measured along a longitudinal axis of the transmitting coil is 300-600 microns,
(b) an outer diameter of the transmitting coil is 100-140 mm, and
(c) a ratio of the outer diameter of the transmitting coil to the height of the transmitting coil is at least 150.
For some applications:
(a) a longitudinal length of the receiving coil is 3-15 mm,
(b) an outer diameter of the receiving coil is 0.6-1.5 mm, and
(c) a ratio of the outer diameter of the receiving coil to the longitudinal length of the receiving coil is less than 0.5.
For some applications:
(a) a first ratio, of the outer diameter of the transmitting coil to a height of the transmitting coil measured along a longitudinal axis of the transmitting coil, is at least 150,
(b) a second ratio, of the outer diameter of the receiving coil to the longitudinal length of the receiving coil, is less than 0.5, and
(c) a ratio of the first ratio to the second ratio is at least 300.
For some applications, the transmitting coil has between 4 and 10 turns.
For some applications, the receiving coil has between 10 and 40 turns.
For some applications, the medical implant is configured to send a signal to the control circuitry upon receiving the transmitted power.
For some applications, a cross-sectional area of a wire of the transmitting coil is rectangular, the cross-section being taken perpendicular to a direction of current flow within the wire.
For some applications, the transmitting coil is elongated in a direction perpendicular to the central longitudinal axis of the receiving coil.
For some applications, a length of the receiving coil is 3-15 mm.
For some applications, the medical implant includes a housing having a length of 30-45 mm and the receiving coil is disposed in within the housing.
For some applications, the apparatus further includes an indicator, and the control circuitry is configured to activate the indicator upon the transmitting coil being in an acceptable position with respect to the receiving coil.
For some applications, the control circuitry is configured to detect interference with its output signal and to activate the indicator upon the detection of the interference.
For some applications, the control circuitry is configured to activate the indicator again, upon the transmitting coil no longer being in correct position with respect to the receiving coil.
For some applications, the control circuitry is configured to ascertain an indication of an efficiency of the power transfer between the transmitting coil and the receiving coil, and to activate the indicator according to the ascertaining.
For some applications, the control circuitry is configured to measure a loss of power in the transmitting coil, the loss of power being indicative of the efficiency of the power transfer.
For some applications, the transmitting coil is a planar coil.
For some applications, a line width of the transmitting coil is 1-4 mm.
For some applications, the planar coil includes a plurality of layers.
For some applications, a line spacing of adjacent coplanar wires in the transmitting coil is 0.25-3 mm.
For some applications, the apparatus further includes a flexible printed circuit board (PCB), and the transmitting coil includes two planar layers disposed on either side of the flexible PCB.
For some applications, a height of each layer measured along a longitudinal axis of the transmitting coil is 15-100 microns.
For some applications, a height of the flexible PCB measured along a longitudinal axis of the transmitting coil is 100-200 microns.
For some applications, respective wires of the two layers are conductively connected to each other at at least one location along each turn of the transmitting coil.
For some applications, the apparatus further includes at least one capacitor, coupled to the transmitting coil at at least one location along at least one turn of the transmitting coil.
For some applications, the capacitor is electrically coupled to both of the two layers.
For some applications, the apparatus further includes a plurality of capacitors coupled to the transmitting coil such that at least one capacitor is coupled to the transmitting coil at at least one location along each turn of the transmitting coil.
For some applications, each of the capacitors is electrically coupled to both of the two layers.
For some applications, an insulating cover is coupled to both layers of the transmitting coil disposed on the flexible PCB.
For some applications, an average distance from a wire of the transmitting coil to the central longitudinal axis of the transmitting coil is less than two times a square root of a cross-sectional area of a central non-coiled region of the transmitting coil.
For some applications, the average distance from the wire of the transmitting coil to the central longitudinal axis of the transmitting coil is 0.6-1.5 times the square root of the cross-sectional area of the central non-coiled region of the transmitting coil.
There is further provided, in accordance with some applications of the present invention, apparatus for use with a medical implant that includes a receiving coil, the apparatus including:
a flexible housing configured to be placed against skin of a subject;
a flexible transmitting coil disposed in the housing;
control circuitry configured to transmit power to the medical implant by driving a current through the transmitting coil that induces an induced current in the receiving coil;
a sensor coupled to the control circuitry, the sensor configured to determine an extent of divergence of (a) a resonance frequency of the transmitting coil when the transmitting coil is flexed from (b) a nominal resonance frequency of the transmitting coil, occurring in the absence of any forces applied to the transmitting coil, and configured to output a signal according to the determination; and
one or more electrical components, coupled to the control circuitry and configured to tune the resonance frequency of the transmitting coil in response to the determination of the sensor.
For some applications, the control circuitry is configured to set the frequency of the current output by the control circuitry to be between 1 and 20 MHz.
For some applications, the flexible transmitting coil is configured to flex such that it can substantially conform to a lateral wall of a cylinder having a diameter between 8 and 50 cm.
For some applications, the sensor includes a phase detector, configured to (a) determine a phase difference between the phase of the current output by the control circuitry, and the phase of either a current or a voltage on at least one component of the transmitting coil, the phase difference being due to flexing of the transmitting coil, and (b) output a signal according to the determination.
For some applications, the control circuitry includes a feedback calculator configured to:
(a) receive the signal output by the phase detector,
(b) determine, according to the signal output by the phase detector, a necessary change in the resonance frequency of the transmitting coil, in order to reduce the extent of divergence of (a) the resonance frequency of the transmitting coil when the transmitting coil is flexed from (b) the nominal resonance frequency of the transmitting coil, and
(c) output a signal to the one or more electrical components, according to the determination.
For some applications, the sensor is configured to:
(a) measure a parameter that is indicative of the frequency of the current output by the control circuitry and the resonance frequency of the transmitting coil,
(b) look up at least one value in a look-up table with respect to the measured parameter, and
(c) output a signal to the one or more electrical components based on the looked-up value.
For some applications, the control circuitry is configured such that the measured parameter is a level of power output by the transmitting coil.
For some applications, at least one of the one or more electrical components is a variable inductor, the control circuitry is configured to vary an inductance of the variable inductor according to the signal output by the sensor, and the resonance frequency of the transmitting coil varies according to the variation of the inductance of the variable inductor.
For some applications, at least one of the one or more electrical components is a variable capacitor, the control circuitry is configured to vary a capacitance of the variable capacitor according to the signal output by the sensor, and the resonance frequency of the transmitting coil varies according to the variation of the capacitance of the variable capacitor.
For some applications, the apparatus further includes a plurality of switches, each switch coupled to a respective one of the electrical components.
For some applications, the control circuitry is configured to tune the resonance frequency of the transmitting coil, according to the signal output by the sensor, by activating at least one of the plurality of switches to facilitate or inhibit current flow through the respective electrical component.
For some applications, the control circuitry is configured to dither the resonance frequency of the transmitting coil by repeatedly activating and deactivating the at least one of the plurality of switches to facilitate or inhibit current flow through the respective electrical component.
For some applications, at least one of the plurality of switches is configured to be manually operated and the remaining switches are configured to be operated by the control circuitry, wherein (a) the electrical component coupled to the manually-operated switch is configured to vary the resonance frequency of the transmitting coil by more than (b) the electrical components coupled to the switches operated by the control circuitry are configured to vary the resonance frequency of the transmitting coil.
For some applications, the one or more electrical components is a plurality of inductors, coupled in series.
For some applications, the plurality of inductors includes 3-9 inductors.
For some applications, a first one of the inductors has an inductance of 1.5-2.5 times an inductance of another one of the inductors.
For some applications, the inductance of the first one of the inductors is twice the inductance of the other one of the inductors.
For some applications, each one of at least half of the inductors has an inductance which is twice an inductance of another one of the inductors.
For some applications, the control circuitry is configured such that when the extent of divergence of (a) the resonance frequency of the transmitting coil when the transmitting coil is flexed from (b) the nominal resonance frequency of the transmitting coil is reduced, current is allowed to pass through at least one of the inductors and current is inhibited from passing through at least another one of the inductors.
For some applications, the one or more electrical components is a plurality of capacitors coupled in parallel.
For some applications, the plurality of capacitors includes 4 to 10 capacitors.
For some applications, a first one of the capacitors has a capacitance of 1.5-2.5 times a capacitance of another one of the capacitors.
For some applications, the capacitance of the first one of the capacitors is twice the capacitance of the other one of the capacitors.
For some applications, each one of at least half of the capacitors has a capacitance that is twice a capacitance of another one of the capacitors.
For some applications, the control circuitry is configured such that when the extent of divergence of (a) the resonance frequency of the transmitting coil when the transmitting coil is flexed from (b) the nominal resonance frequency of the transmitting coil is reduced, current is allowed to pass through at least one of the capacitors and current is inhibited from passing through at least another one of the capacitors.
For some applications, the one or more electrical components is a plurality of electrical components including inductors, coupled in series, and capacitors, coupled in parallel.
For some applications, a first one of the inductors has an inductance of 1.5-2.5 times an inductance of another one of the inductors.
For some applications, the inductance of the first one of the inductors is twice the inductance of the other one of the inductors.
For some applications, each one of at least half of the inductors has an inductance that is twice an inductance of another one of the inductors.
For some applications, a first one of the capacitors has a capacitance of 1.5-2.5 times a capacitance of another one of the capacitors.
For some applications, the capacitance of the first one of the capacitors is twice the capacitance of the other one of the capacitors.
For some applications, each one of at least half of the capacitors has a capacitance that is twice a capacitance of another one of the capacitors.
For some applications, the control circuitry is configured such that when the extent of divergence of (a) the resonance frequency of the transmitting coil when the transmitting coil is flexed from (b) the nominal resonance frequency of the transmitting coil is reduced, current is allowed to pass through at least one of the electrical components and current is inhibited from passing through at least another one of the electrical components.
For some applications:
the control circuitry is configured to activate the switches by applying a respective voltage of 30-300 volts to each switch,
the switches include transistors, acting as diodes, having respective capacitances that are dependent on the respective voltage applied to each switch.
For some applications, the control circuitry is configured to apply the respective voltages to the respective switches at a voltage of 50-200 volts.
For some applications:
the control circuitry is configured to activate the switches by applying a respective voltage of 30-300 volts to each switch, and
the switches include transistors, which behave in their off states as variable capacitors, having respective capacitances that are dependent on the respective voltage applied to each switch.
For some applications, the control circuitry is configured to apply the respective voltages to the respective switches at a voltage of 50-200 volts.
For some applications, the apparatus further includes the medical implant.
There is further provided, in accordance with some applications of the present invention, a method for treating a subject suffering from migraines or cluster headaches, the method including:
identifying the subject as suffering from migraines or cluster headaches; and
in response to the identifying, powering a medical implant to stimulate a tibial nerve in a leg of the subject.
The present invention will be more fully understood from the following detailed description of applications thereof, taken together with the drawings, in which:
Reference is made to
As used in the present application, including in the claims, a “central longitudinal axis” of an elongate structure is the set of all centroids of transverse cross-sectional sections of the structure along the structure. Thus, the cross-sectional sections are locally perpendicular to the central longitudinal axis, which runs along the structure. (If the structure is circular in cross-section, the centroids correspond with the centers of the circular cross-sectional sections.)
As used in the present application, including in the claims, substantially parallel elements are to be understood as having an angle between them that is less than 10 degrees. For some applications, substantially parallel elements have an angle between them that is less than 5 degrees.
As used in the present application, including in the claims, substantially perpendicular elements are to be understood as having an angle between them that is at least 85 degrees and/or less than 95 degrees.
Reference is now made to
Therefore, taking into account the limited space available near the ankle, the desired orientation of the generated magnetic fields is accomplished by placing transmitting coil housing 22 against skin 28 such that transmitting coil 20, having a wire disposed at all rotational locations about central longitudinal axis 34, is not centered over receiving coil 24. Rather, only a portion 50 (
For some applications, medical implant 23 is implanted on a leg between the knee and the ankle, as described hereinabove, in order to treat patients suffering from migraines or cluster headaches using tibial nerve stimulation. Transmitting coil 20 powers medical implant 23 in order to provide neural stimulation to the tibial nerve, for example at a repetition rate of 10-60 Hz. Similarly to over-stimulation of the ulnar nerve for treatment of migraines, over-stimulation of the tibial nerve may cause paresthesia in the active pain centers in the brain, thereby reducing the pain of the migraine or cluster headache.
Reference is now made to
In order to further improve the efficiency of the power transfer, transmitting coil 20 is typically elongated in a direction perpendicular to central longitudinal axis 32 of receiving coil 24 thus increasing a distance between central longitudinal axis 34 and a wire of transmitting coil 20. Therefore, magnetic fields generated by the current in transmitting coil 20, e.g., magnetic field 54, that are not substantially parallel to receiving coil 24, are farther away from receiving coil 24 thereby they have less of an effect on the induced current in receiving coil 24. For some applications, an average distance D10 (
Efficiency of the power transfer is also affected by a depth of implantation of medical implant 23. Typically, medical implant 23 is implanted at a depth D14 (
Reference is again made to
For some applications, control circuitry 36 is able to detect when transmitting coil 20 is in an acceptable position by outputting a signal and subsequently detecting an interference, caused by receiving coil 24, with the signal. Upon detection of the interference, control circuitry 36 activates indicator 48.
Alternatively or additionally, control circuitry 36 is able to ascertain an indication of the efficiency of the energy transmission between transmitting coil 20 and receiving coil 24, and indicator 48 is configured to have a range of indications that are respectively representative of the efficiency ascertained by control circuitry 36. For some applications, the indication of the efficiency is a measurement of power loss in transmitting coil 20. Power loss in transmitting coil 20 may include one or more of the following: (a) power losses that do not appreciably change with the positioning of the transmitting coil, such as losses due to unavoidable resistance of transmitting coil 20 and other losses in the transmitting electronics, and (b) losses in the power transmitted to medical implant 23 which depend on the relative positioning of transmitting coil 20 and receiving coil 24, such as absorption of power in the tissue and surrounding structures. Thus, monitoring the power loss in transmitting coil 20 may facilitate proper positioning of transmitting coil 20 in relation to medical implant 23.
Alternatively or additionally, medical implant 23 is configured to send an output signal to control circuitry 36 upon receiving transmitted power from transmitting coil 20. This output signal may include data indicative of the power received by receiving coil 24 in medical implant 23. Control circuitry 36 receives the data indicative of the power received by receiving coil 24 in medical implant 23, and by comparing it to the power transmitted by transmitting coil 20, determines a parameter indicative of the efficiency of the power transmission. This parameter may be used to indicate to the user: a) if the efficiency is within a range of acceptable values; and b) if repositioning transmitting coil housing 22 has caused an increase or decrease in the power transmission. The indication may be used by a healthcare provider, during an initial training session, to train the patient or family member to correctly position transmitting coil housing 22. Similarly, the indication may be used by the patient or family member each time transmitting coil housing 22 has to be placed on the patient or repositioned. For some applications, the output signal from medical implant 23, indicative of the power received by receiving coil 24, is sent only when needed. For example, the output signal from medical implant 23 may be sent (a) when medical implant 23 is powered-up, (b) during positioning of transmitting coil 20, or (c) when the power received by receiving coil 24 in medical implant 23 is changed unexpectedly, indicating a possible movement of transmitting coil 20 relative to receiving coil 24.
Transmitting coil housing 22 can be positioned on skin 28 by placing housing 22 against skin 28 and subsequently sliding transmitting coil housing 22 along skin 28 until indicator 48 indicates that transmitting coil 20 is in an acceptable position with respect to receiving coil 24. In some applications, control circuitry 36 is further configured to activate indicator 48 again upon transmitting coil 20 no longer being in an acceptable position with respect to receiving coil 24.
Reference is now made to
One or more dimensions of transmitting coil 20 that highlight the planar properties of transmitting coil 20 are as follows:
As used in the present application, including in the claims, outer diameter D6 of transmitting coil 20 is the largest dimension of transmitting coil 20 from one side of the coil to the other, measured perpendicular to central longitudinal axis 34 of transmitting coil 20.
Typically, a cross-sectional area 108 of the wire of transmitting coil 20 is rectangular when the cross-section, e.g., cross-section A-A shown in
Typically, receiving coil 24 is a cylindrical coil having 10-40 turns, e.g., 20 turns, and comprising a ferrite core. For some applications, one or more dimensions of receiving coil 24 are as follows:
Typically, receiving coil housing 26 is longitudinally longer than receiving coil 24, to accommodate for control circuitry disposed within medical implant 23. For some applications, a longitudinal length D11 of receiving coil housing 26 is at least 30 mm and/or less than 45 mm. Medical implant 23 may also comprise a plurality of electrodes.
For some applications, some dimensional relationships between transmitting coil 20 and receiving coil 24 are expressed according to a set of one or more of the following options:
Reference is now made to
Additionally, a capacitor 102 is coupled to transmitting coil 20 at at least one location along at least one turn of transmitting coil 20. Typically, capacitor 102 is attached to an exposed pad 92 of one of planar layers 94 or 96. For some applications, as seen in
Typically, an insulating cover 104 is coupled, e.g., glued, to both planar layers 94 and 96 of transmitting coil 20 on flexible PCB 98. For some applications, a thickness D17 of a layer of glue 106 between cover 104 and each planar layer 94 and 96 is 15-50 microns. For some applications, a thickness D18 of cover 104 is 15-100 microns.
Reference is now made to
Reference is now made to
For some applications, sensor 58 comprises a phase detector 60 and a feedback calculator 62 (for example, as shown in
For some applications (e.g., as shown in
For some applications, at least one of the electrical components is a variable inductor 66 (
For some applications, at least one of the electrical components is a variable capacitor 68 (
For some applications, the one or more electrical components is a (a) a plurality of inductors 70, e.g., 3-9 inductors 70, coupled in series (
Typically, control circuitry 36 tunes the resonance frequency of transmitting coil 20, according to the signal output by sensor 58, by activating and/or deactivating at least one of a plurality of switches 74, each switch 74 being coupled to a respective one of the electrical components, in order to facilitate or inhibit current flow through the respective electrical component. In order to easily be able to increase and decrease the resonance frequency of transmitting coil 20, as necessary according to the signal output by sensor 58, control circuitry 36 is configured such that, when the extent of divergence of (a) the resonance frequency of transmitting coil 20 when transmitting coil 20 is flexed from (b) the nominal resonance frequency of transmitting coil 20 is reduced, at least one of switches 74 is activated, allowing current to flow through a respective electrical component, and at least another switch 74 is deactivated, inhibiting current from flowing through another respective electrical component. For some applications, control circuitry 36 is configured to dither the resonance frequency of transmitting coil 20 by repeatedly activating and deactivating at least one of switches 74 to alternatingly facilitate and inhibit current flow through a respective electrical component.
For some applications, a wider range of variation of the resonance frequency of transmitting coil 20 may be achieved by having at least one electrical component (a) configured to vary the resonance frequency of transmitting coil 20 by more than the remaining electrical components are configured to vary the resonance frequency of transmitting coil 20 and (b) coupled to a manually-operated switch. The manually-operated switch may be activated and/or deactivated by a user to provide gross tuning of the resonance frequency of transmitting coil 20 and the remaining switches 74 activated and/or deactivated by control circuitry 36 to provide fine tuning of the resonance frequency of transmitting coil 20.
Reference is now made to
Reference is now made to
It will be appreciated by persons skilled in the art that the present invention is not limited to what has been particularly shown and described hereinabove. Rather, the scope of the present invention includes both combinations and subcombinations of the various features described hereinabove, as well as variations and modifications thereof that are not in the prior art, which would occur to persons skilled in the art upon reading the foregoing description.
The present application is a Continuation of U.S. Ser. No. 16/737,253 to Oron et al., entitled “Antenna configuration,” which published as U.S. 2020/0,139,136, and which is a Divisional of U.S. Ser. No. 15/621,433 to Oron et al. (abandoned), filed Jun. 13, 2017, entitled, “Antenna configuration.”
Number | Name | Date | Kind |
---|---|---|---|
3411507 | Wingrove | Nov 1968 | A |
3693625 | Auphan | Sep 1972 | A |
3727616 | Lenzkes | Apr 1973 | A |
4019518 | Maurer et al. | Apr 1977 | A |
4338945 | Kosugi et al. | Jul 1982 | A |
4392496 | Stanton | Jul 1983 | A |
4535785 | Van Den Honert | Aug 1985 | A |
4559948 | Liss et al. | Dec 1985 | A |
4573481 | Bullara | Mar 1986 | A |
4585005 | Lue et al. | Apr 1986 | A |
4602624 | Naples | Jul 1986 | A |
4608985 | Crish | Sep 1986 | A |
4628942 | Sweeney | Dec 1986 | A |
4632116 | Rosen | Dec 1986 | A |
4649936 | Ungar | Mar 1987 | A |
4663102 | Brenman et al. | May 1987 | A |
4739764 | Lau | Apr 1988 | A |
4741339 | Harrison et al. | May 1988 | A |
4808157 | Coombs | Feb 1989 | A |
4867164 | Zabara | Sep 1989 | A |
4926865 | Oman | May 1990 | A |
4962751 | Krauter | Oct 1990 | A |
5025807 | Zabara | Jun 1991 | A |
5036854 | Schollmeyer et al. | Aug 1991 | A |
5069680 | Grandjean | Dec 1991 | A |
5178161 | Kovacs | Jan 1993 | A |
5188104 | Wernicke | Feb 1993 | A |
5199428 | Obel et al. | Apr 1993 | A |
5199430 | Fang | Apr 1993 | A |
5203326 | Collins | Apr 1993 | A |
5205285 | Baker, Jr. | Apr 1993 | A |
5215086 | Terry, Jr. | Jun 1993 | A |
5263480 | Wernicke | Nov 1993 | A |
5282468 | Klepinski | Feb 1994 | A |
5284479 | De Jong | Feb 1994 | A |
5292344 | Douglas | Mar 1994 | A |
5299569 | Wernicke | Apr 1994 | A |
5314453 | Jeutter | May 1994 | A |
5314495 | Kovacs | May 1994 | A |
5330507 | Schwartz | Jul 1994 | A |
5335657 | Terry, Jr. | Aug 1994 | A |
5411535 | Fujii et al. | May 1995 | A |
5423872 | Cigaina | Jun 1995 | A |
5439938 | Synder et al. | Aug 1995 | A |
5454840 | Krakovsky et al. | Oct 1995 | A |
5487760 | Villafana | Jan 1996 | A |
5505201 | Grill, Jr. | Apr 1996 | A |
5509924 | Paspa et al. | Apr 1996 | A |
5540730 | Terry, Jr. | Jul 1996 | A |
5540733 | Testerman et al. | Jul 1996 | A |
5540734 | Zabara | Jul 1996 | A |
5549655 | Erickson | Aug 1996 | A |
5571150 | Wernicke | Nov 1996 | A |
5591216 | Testerman et al. | Jan 1997 | A |
5634462 | Tyler et al. | Jun 1997 | A |
5690681 | Geddes et al. | Nov 1997 | A |
5690691 | Chen | Nov 1997 | A |
5700282 | Zabara | Dec 1997 | A |
5707400 | Terry, Jr. | Jan 1998 | A |
5711316 | Elsberry et al. | Jan 1998 | A |
5716385 | Mittal | Feb 1998 | A |
5755750 | Petruska | May 1998 | A |
5776170 | Macdonald et al. | Jul 1998 | A |
5776171 | Peckham | Jul 1998 | A |
5814089 | Stokes | Sep 1998 | A |
5824027 | Hoffer et al. | Oct 1998 | A |
5832932 | Elsberry et al. | Nov 1998 | A |
5833709 | Rise et al. | Nov 1998 | A |
5836994 | Bourgeois | Nov 1998 | A |
5861019 | Sun et al. | Jan 1999 | A |
5898579 | Boys et al. | Apr 1999 | A |
5916239 | Geddes et al. | Jun 1999 | A |
5938584 | Ardito et al. | Aug 1999 | A |
5944680 | Christopherson | Aug 1999 | A |
5954758 | Peckham | Sep 1999 | A |
5991664 | Seligman | Nov 1999 | A |
6002964 | Feler et al. | Dec 1999 | A |
6026326 | Bardy | Feb 2000 | A |
6026328 | Peckham | Feb 2000 | A |
6032076 | Melvin et al. | Feb 2000 | A |
6058331 | King et al. | May 2000 | A |
6066163 | John | May 2000 | A |
6070803 | Stobbe | Jun 2000 | A |
6071274 | Thompson et al. | Jun 2000 | A |
6091992 | Bourgeois | Jun 2000 | A |
6083249 | Familoni | Jul 2000 | A |
6086525 | Davey et al. | Jul 2000 | A |
6091977 | Tarjan et al. | Jul 2000 | A |
6094598 | Elsberry et al. | Jul 2000 | A |
6097984 | Douglas | Aug 2000 | A |
6104955 | Bourgeois | Aug 2000 | A |
6104960 | Duysens et al. | Aug 2000 | A |
6119516 | Hock | Sep 2000 | A |
6146335 | Gozani | Nov 2000 | A |
6148232 | Avrahami | Nov 2000 | A |
6161048 | Sluijter et al. | Dec 2000 | A |
6169924 | Meloy et al. | Jan 2001 | B1 |
6205359 | Boveja | Mar 2001 | B1 |
6212435 | Lattner et al. | Apr 2001 | B1 |
6214032 | Loeb et al. | Apr 2001 | B1 |
6230061 | Hartung | May 2001 | B1 |
6240316 | Richmond | May 2001 | B1 |
6246912 | Sluijter et al. | Jun 2001 | B1 |
6266564 | Schwartz | Jul 2001 | B1 |
6272383 | Grey | Aug 2001 | B1 |
6292703 | Meier et al. | Sep 2001 | B1 |
6319241 | King | Nov 2001 | B1 |
6332089 | Acker | Dec 2001 | B1 |
6341236 | Osorio et al. | Jan 2002 | B1 |
6345202 | Richmond et al. | Feb 2002 | B2 |
6356784 | Lozano et al. | Mar 2002 | B1 |
6356788 | Boveja | Mar 2002 | B2 |
6366813 | Dilorenzo | Apr 2002 | B1 |
6405079 | Ansarinia | Jun 2002 | B1 |
6442432 | Lee | Aug 2002 | B2 |
6445953 | Bulkes et al. | Sep 2002 | B1 |
6449507 | Hill et al. | Sep 2002 | B1 |
6456878 | Yerich et al. | Sep 2002 | B1 |
6463328 | John | Oct 2002 | B1 |
6473644 | Terry, Jr. et al. | Oct 2002 | B1 |
6496729 | Thompson | Dec 2002 | B2 |
6496730 | Kleckner et al. | Dec 2002 | B1 |
6582441 | He et al. | Jun 2003 | B1 |
6591139 | Loftin et al. | Jul 2003 | B2 |
6600954 | Cohen | Jul 2003 | B2 |
6600956 | Maschino et al. | Jul 2003 | B2 |
6606521 | Paspa et al. | Aug 2003 | B2 |
6610713 | Tracey | Aug 2003 | B2 |
6618627 | Lattner et al. | Sep 2003 | B2 |
6641542 | Cho et al. | Nov 2003 | B2 |
6682480 | Habib et al. | Jan 2004 | B1 |
6712772 | Cohen et al. | Mar 2004 | B2 |
6721603 | Zabara et al. | Apr 2004 | B2 |
6735474 | Loeb et al. | May 2004 | B1 |
6735475 | Whitehurst et al. | May 2004 | B1 |
6770022 | Mechlenburg | Aug 2004 | B2 |
6788973 | Davis et al. | Sep 2004 | B2 |
6788975 | Whitehurst et al. | Sep 2004 | B1 |
6804561 | Stover | Oct 2004 | B2 |
6829508 | Schulman | Dec 2004 | B2 |
6839594 | Cohen | Jan 2005 | B2 |
6892098 | Ayal | May 2005 | B2 |
6907295 | Gross et al. | Jun 2005 | B2 |
6909917 | Woods et al. | Jun 2005 | B2 |
6950706 | Rodriguez et al. | Sep 2005 | B2 |
6993384 | Bradley et al. | Jan 2006 | B2 |
7015769 | Schulman et al. | Mar 2006 | B2 |
7025730 | Cho et al. | Apr 2006 | B2 |
7027860 | Bruninga et al. | Apr 2006 | B2 |
7047076 | Li et al. | May 2006 | B1 |
7054689 | Whitehurst et al. | May 2006 | B1 |
7054692 | Whitehurst et al. | May 2006 | B1 |
7110820 | Tcheng et al. | Sep 2006 | B2 |
7149575 | Ostroff et al. | Dec 2006 | B2 |
7151914 | Brewer | Dec 2006 | B2 |
7174218 | Kuzma | Feb 2007 | B1 |
7177690 | Woods et al. | Feb 2007 | B2 |
7177698 | Klosterman et al. | Feb 2007 | B2 |
7190153 | Stover et al. | Mar 2007 | B2 |
7190998 | Shalev et al. | Mar 2007 | B2 |
7203549 | Schommer et al. | Apr 2007 | B2 |
7209792 | Parramon et al. | Apr 2007 | B1 |
7212867 | Venrooij et al. | May 2007 | B2 |
7216000 | Sieracki et al. | May 2007 | B2 |
7225032 | Schmeling et al. | May 2007 | B2 |
7228178 | Carroll | Jun 2007 | B2 |
7239921 | Canfield et al. | Jul 2007 | B2 |
7242982 | Singhal et al. | Jul 2007 | B2 |
7254449 | Karunasiri | Aug 2007 | B2 |
7263402 | Thacker et al. | Aug 2007 | B2 |
7277748 | Wingeier et al. | Oct 2007 | B2 |
7277749 | Gordon et al. | Oct 2007 | B2 |
7286880 | Olson et al. | Oct 2007 | B2 |
7286881 | Schommer et al. | Oct 2007 | B2 |
7289853 | Campbell et al. | Oct 2007 | B1 |
7292890 | Whitehurst et al. | Nov 2007 | B2 |
7308316 | Schommer | Dec 2007 | B2 |
7324852 | Barolat et al. | Jan 2008 | B2 |
7324853 | Ayal | Jan 2008 | B2 |
7330756 | Marnfeldt | Feb 2008 | B2 |
7337007 | Nathan et al. | Feb 2008 | B2 |
7342508 | Morgan et al. | Mar 2008 | B2 |
7363087 | Nghiem et al. | Apr 2008 | B2 |
7376466 | He et al. | May 2008 | B2 |
7389145 | Kilgore et al. | Jun 2008 | B2 |
7483748 | Torgerson et al. | Jan 2009 | B2 |
7483752 | Von arx et al. | Jan 2009 | B2 |
7489561 | Armstrong et al. | Feb 2009 | B2 |
7502652 | Gaunt et al. | Mar 2009 | B2 |
7515012 | Schulman et al. | Apr 2009 | B2 |
7515967 | Phillips et al. | Apr 2009 | B2 |
7532932 | Denker et al. | May 2009 | B2 |
7536226 | Williams | May 2009 | B2 |
7539538 | Parramon et al. | May 2009 | B2 |
7561921 | Phillips et al. | Jul 2009 | B2 |
7565204 | Matei | Jul 2009 | B2 |
7628750 | Cohen | Dec 2009 | B2 |
7630771 | Cauller | Dec 2009 | B2 |
7634313 | Kroll et al. | Dec 2009 | B1 |
7643147 | Pless | Jan 2010 | B2 |
7647117 | Bauhahn | Jan 2010 | B2 |
7650192 | Wahlstrand | Jan 2010 | B2 |
7655014 | Ko et al. | Feb 2010 | B2 |
7657311 | Bardy et al. | Feb 2010 | B2 |
7657317 | Thacker et al. | Feb 2010 | B2 |
7657322 | Bardy et al. | Feb 2010 | B2 |
7660632 | Kirby et al. | Feb 2010 | B2 |
7680538 | Durand et al. | Mar 2010 | B2 |
7680540 | Jensen et al. | Mar 2010 | B2 |
7711434 | Denker et al. | May 2010 | B2 |
7736379 | Ewers et al. | Jun 2010 | B2 |
7747325 | Dilorenzo | Jun 2010 | B2 |
7748344 | Divergilio et al. | Jul 2010 | B2 |
7780625 | Bardy | Aug 2010 | B2 |
7797050 | Libbus et al. | Sep 2010 | B2 |
7801602 | McClure et al. | Sep 2010 | B2 |
7803142 | Longson et al. | Sep 2010 | B2 |
7809437 | Palmer et al. | Oct 2010 | B2 |
7817280 | Pless | Oct 2010 | B2 |
7822480 | Park et al. | Oct 2010 | B2 |
7848818 | Barolat et al. | Dec 2010 | B2 |
7869867 | Armstrong et al. | Jan 2011 | B2 |
7894905 | Pless et al. | Feb 2011 | B2 |
7899547 | Emadi et al. | Mar 2011 | B1 |
7899556 | Nathan et al. | Mar 2011 | B2 |
7904171 | Parramon et al. | Mar 2011 | B2 |
7912551 | Wosmek | Mar 2011 | B2 |
7925350 | Palmer | Apr 2011 | B1 |
7917226 | Nghiem | May 2011 | B2 |
7937148 | Jacobson | May 2011 | B2 |
7941218 | Sambelashvili et al. | May 2011 | B2 |
7962211 | Torgerson et al. | Jun 2011 | B2 |
7962220 | Kolafa et al. | Jun 2011 | B2 |
7974706 | Moffitt et al. | Jul 2011 | B2 |
7979126 | Payne et al. | Jul 2011 | B2 |
7991467 | Markowitz et al. | Aug 2011 | B2 |
7996079 | Armstrong | Aug 2011 | B2 |
7996089 | Haugland et al. | Aug 2011 | B2 |
7996092 | Mrva et al. | Aug 2011 | B2 |
8005547 | Forsberg et al. | Aug 2011 | B2 |
8019443 | Scheicher et al. | Sep 2011 | B2 |
8050771 | Yamamoto et al. | Nov 2011 | B2 |
8055336 | Schulman et al. | Nov 2011 | B1 |
8055350 | Roberts | Nov 2011 | B2 |
8075556 | Betts | Dec 2011 | B2 |
8086313 | Singhal et al. | Dec 2011 | B2 |
8090438 | Bardy et al. | Jan 2012 | B2 |
8092412 | Sherman | Jan 2012 | B2 |
8115448 | John | Feb 2012 | B2 |
8127424 | Haller et al. | Mar 2012 | B2 |
8131377 | Shhi et al. | Mar 2012 | B2 |
8140168 | Olson et al. | Mar 2012 | B2 |
8170675 | Alataris et al. | May 2012 | B2 |
8170681 | Jimenez et al. | May 2012 | B2 |
8175719 | Shi et al. | May 2012 | B2 |
8177792 | Lubock et al. | May 2012 | B2 |
8185207 | Molnar et al. | May 2012 | B2 |
8209021 | Alataris et al. | Jun 2012 | B2 |
8219205 | Tseng et al. | Jul 2012 | B2 |
8224453 | De Ridder | Jul 2012 | B2 |
8229567 | Phillips et al. | Jul 2012 | B2 |
8244367 | Wahlstrand et al. | Aug 2012 | B2 |
8255057 | Fang et al. | Aug 2012 | B2 |
8260432 | DiGiore et al. | Sep 2012 | B2 |
8265770 | Toy et al. | Sep 2012 | B2 |
8306627 | Armstrong | Nov 2012 | B2 |
8311638 | Aghassian | Nov 2012 | B2 |
8321028 | Thenuwara et al. | Nov 2012 | B1 |
8335569 | Aghassian | Dec 2012 | B2 |
8355792 | Alataris et al. | Jan 2013 | B2 |
8359102 | Alataris et al. | Jan 2013 | B2 |
8359103 | Alataris et al. | Jan 2013 | B2 |
8364267 | Schleicher et al. | Jan 2013 | B2 |
8369963 | Parramon et al. | Feb 2013 | B2 |
8374700 | Haubrich et al. | Feb 2013 | B2 |
8386047 | Koester | Feb 2013 | B2 |
8386048 | McClure et al. | Feb 2013 | B2 |
8396559 | Alataris et al. | Mar 2013 | B2 |
8428731 | Armstrong | Apr 2013 | B2 |
8428744 | Stancer et al. | Apr 2013 | B2 |
8428746 | DiGiore et al. | Apr 2013 | B2 |
8428748 | Alataris et al. | Apr 2013 | B2 |
8437846 | Swoyer et al. | May 2013 | B2 |
8437853 | Inman et al. | May 2013 | B2 |
8457744 | Janzig et al. | Jun 2013 | B2 |
8457759 | Parker et al. | Jun 2013 | B2 |
8463404 | Levi et al. | Jun 2013 | B2 |
8473066 | Aghassian et al. | Jun 2013 | B2 |
8478420 | Armstrong et al. | Jul 2013 | B2 |
8483838 | Nghiem et al. | Jul 2013 | B2 |
8483845 | Sage | Jul 2013 | B2 |
8494640 | Peterson et al. | Jul 2013 | B2 |
8494650 | Glukhovsky et al. | Jul 2013 | B2 |
8497804 | Haubrich et al. | Jul 2013 | B2 |
8498716 | Chen et al. | Jul 2013 | B2 |
8509905 | Alataris et al. | Aug 2013 | B2 |
8509906 | Walker et al. | Aug 2013 | B2 |
8515558 | Zweber et al. | Aug 2013 | B1 |
8538548 | Shi et al. | Sep 2013 | B2 |
8543200 | Lane et al. | Sep 2013 | B2 |
8554326 | Alataris et al. | Oct 2013 | B2 |
8555894 | Schulman et al. | Oct 2013 | B2 |
8571651 | Ben-ezra et al. | Oct 2013 | B2 |
8577474 | Rahman et al. | Nov 2013 | B2 |
8588933 | Floyd et al. | Nov 2013 | B2 |
8612014 | Rahman et al. | Dec 2013 | B2 |
8612019 | Moffitt | Dec 2013 | B2 |
8620435 | Rooney et al. | Dec 2013 | B2 |
8620449 | Zhao et al. | Dec 2013 | B2 |
8626310 | Barror et al. | Jan 2014 | B2 |
8634927 | Olson et al. | Jan 2014 | B2 |
8644947 | Zhu et al. | Feb 2014 | B2 |
8644948 | Grevious et al. | Feb 2014 | B2 |
8649874 | Alataris et al. | Feb 2014 | B2 |
8660655 | Peterson et al. | Feb 2014 | B2 |
8665086 | Miller et al. | Mar 2014 | B2 |
8666491 | Chen et al. | Mar 2014 | B2 |
8666504 | Dronov et al. | Mar 2014 | B2 |
8676337 | Kallmyer | Mar 2014 | B2 |
8676341 | Kane et al. | Mar 2014 | B2 |
8688232 | Finley et al. | Apr 2014 | B2 |
8694108 | Alataris et al. | Apr 2014 | B2 |
8694109 | Alataris et al. | Apr 2014 | B2 |
8712533 | Alataris et al. | Apr 2014 | B2 |
8712534 | Wei | Apr 2014 | B2 |
8718780 | Lee | May 2014 | B2 |
8718781 | Alataris et al. | May 2014 | B2 |
8718782 | Alataris et al. | May 2014 | B2 |
8738145 | Goetz et al. | May 2014 | B2 |
8750985 | Parramon et al. | Jun 2014 | B2 |
8751009 | Wacnik | Jun 2014 | B2 |
8755893 | Gross et al. | Jun 2014 | B2 |
8761895 | Stevenson et al. | Jun 2014 | B2 |
8768472 | Fang et al. | Jul 2014 | B2 |
8774912 | Gerber | Jul 2014 | B2 |
8774926 | Alataris et al. | Jul 2014 | B2 |
8788045 | Gross et al. | Jul 2014 | B2 |
8792988 | Alataris et al. | Jul 2014 | B2 |
8798773 | Mashiach | Aug 2014 | B2 |
8805519 | Parker et al. | Aug 2014 | B2 |
8812135 | Mashiach | Aug 2014 | B2 |
8831730 | Mashiach et al. | Sep 2014 | B2 |
8843203 | Lee et al. | Sep 2014 | B2 |
8849410 | Walker et al. | Sep 2014 | B2 |
8849412 | Perryman et al. | Sep 2014 | B2 |
8862239 | Alataris et al. | Oct 2014 | B2 |
8868192 | Alataris et al. | Oct 2014 | B2 |
8874217 | Alataris et al. | Oct 2014 | B2 |
8874219 | Trier et al. | Oct 2014 | B2 |
8874221 | Alataris et al. | Oct 2014 | B2 |
8874222 | Alataris et al. | Oct 2014 | B2 |
8880177 | Alataris et al. | Nov 2014 | B2 |
8884779 | Herman et al. | Nov 2014 | B2 |
8886326 | Alataris et al. | Nov 2014 | B2 |
8886327 | Alataris et al. | Nov 2014 | B2 |
8886328 | Alataris et al. | Nov 2014 | B2 |
8892209 | Alataris et al. | Nov 2014 | B2 |
8892214 | Bonde et al. | Nov 2014 | B2 |
8903497 | Norgaard et al. | Dec 2014 | B2 |
8903499 | Pless et al. | Dec 2014 | B2 |
8903515 | Mashiach | Dec 2014 | B2 |
8918179 | Peterson et al. | Dec 2014 | B2 |
8918180 | Peterson | Dec 2014 | B2 |
8923988 | Bradley | Dec 2014 | B2 |
8942808 | Peterson et al. | Jan 2015 | B2 |
8948871 | Mashiach et al. | Feb 2015 | B2 |
8954165 | Sharma et al. | Feb 2015 | B2 |
8958884 | Kothandaraman et al. | Feb 2015 | B2 |
8958891 | Kane et al. | Feb 2015 | B2 |
8983615 | Tahmasian et al. | Mar 2015 | B2 |
8983618 | Yamamoto et al. | Mar 2015 | B2 |
8989864 | Funderburk et al. | Mar 2015 | B2 |
8989868 | Mashiach et al. | Mar 2015 | B2 |
8994325 | Carbunaru et al. | Mar 2015 | B2 |
8996115 | Trier et al. | Mar 2015 | B2 |
9002445 | Chen | Apr 2015 | B2 |
9002460 | Parker | Apr 2015 | B2 |
9002461 | Walker et al. | Apr 2015 | B2 |
9002466 | Trier et al. | Apr 2015 | B2 |
9020599 | Rooney et al. | Apr 2015 | B2 |
9020602 | Aghassian | Apr 2015 | B2 |
9026227 | Daglow | May 2015 | B2 |
9030159 | Chen et al. | May 2015 | B2 |
9031653 | Mashiach | May 2015 | B2 |
9031666 | Fell | May 2015 | B2 |
9037261 | Bradley | May 2015 | B2 |
9042997 | Rahman et al. | May 2015 | B2 |
9044616 | Chen et al. | Jun 2015 | B2 |
9056206 | Torgerson et al. | Jun 2015 | B2 |
9061140 | Shi et al. | Jun 2015 | B2 |
9061151 | Mashiach et al. | Jun 2015 | B2 |
9061159 | Rahman | Jun 2015 | B2 |
9061162 | Mashiach et al. | Jun 2015 | B2 |
9067072 | Tahmasian et al. | Jun 2015 | B2 |
9070507 | Dronov et al. | Jun 2015 | B2 |
9072896 | Dar et al. | Jul 2015 | B2 |
9079041 | Park et al. | Jul 2015 | B2 |
9084900 | Hershey et al. | Jul 2015 | B2 |
9089712 | Joshi et al. | Jul 2015 | B2 |
9095725 | Mashiach | Aug 2015 | B2 |
9095726 | Parramon et al. | Aug 2015 | B2 |
9101774 | Mashiach et al. | Aug 2015 | B2 |
9119969 | Vansickle | Sep 2015 | B2 |
9142989 | Fell et al. | Sep 2015 | B2 |
9149635 | Denison et al. | Oct 2015 | B2 |
9149643 | Tahmasian et al. | Oct 2015 | B2 |
9154219 | Polefko et al. | Oct 2015 | B2 |
9155899 | Mashiach et al. | Oct 2015 | B2 |
9155901 | Dearden et al. | Oct 2015 | B2 |
9162068 | Dronov | Oct 2015 | B2 |
9174051 | Marnfeldt et al. | Nov 2015 | B2 |
9174053 | Zhu | Nov 2015 | B2 |
9186504 | Gross | Nov 2015 | B2 |
9192770 | Wang et al. | Nov 2015 | B2 |
9199083 | Caparso et al. | Dec 2015 | B2 |
9205258 | Simon et al. | Dec 2015 | B2 |
9211418 | Aghassian | Dec 2015 | B2 |
9216297 | Kast et al. | Dec 2015 | B2 |
9220907 | Mashiach et al. | Dec 2015 | B2 |
9220908 | Mashiach | Dec 2015 | B2 |
9220909 | Carbunaru et al. | Dec 2015 | B2 |
9220910 | Colborn | Dec 2015 | B2 |
9225194 | Joshi | Dec 2015 | B2 |
D747491 | Thompson et al. | Jan 2016 | S |
9227075 | Aghassian et al. | Jan 2016 | B2 |
9232903 | Pless et al. | Jan 2016 | B2 |
9238138 | Lee et al. | Jan 2016 | B2 |
9240630 | Joshi | Jan 2016 | B2 |
9242106 | Klosterman et al. | Jan 2016 | B2 |
9248279 | Chen et al. | Feb 2016 | B2 |
9248292 | Trier et al. | Feb 2016 | B2 |
9248302 | Mashiach et al. | Feb 2016 | B2 |
9252604 | Kim | Feb 2016 | B2 |
9254393 | Perryman et al. | Feb 2016 | B2 |
9259571 | Straka et al. | Feb 2016 | B2 |
9259582 | Joshi et al. | Feb 2016 | B2 |
9259584 | Bauhahn et al. | Feb 2016 | B2 |
9265941 | Van Den Biggelaar et al. | Feb 2016 | B2 |
9265958 | Joshi et al. | Feb 2016 | B2 |
9289616 | Koester | Mar 2016 | B2 |
9295841 | Fang et al. | Mar 2016 | B2 |
9295850 | Kallmyer | Mar 2016 | B2 |
9314613 | Mashiach | Apr 2016 | B2 |
9314628 | North et al. | Apr 2016 | B2 |
9314642 | Ozawa et al. | Apr 2016 | B2 |
9320847 | Rooney et al. | Apr 2016 | B2 |
9320899 | Parramon et al. | Apr 2016 | B2 |
9320908 | Fletcher et al. | Apr 2016 | B2 |
9327132 | Mashiach | May 2016 | B2 |
9333367 | Chen | May 2016 | B2 |
9339660 | Feldman et al. | May 2016 | B2 |
9343923 | Joshi | May 2016 | B2 |
9352161 | Thacker et al. | May 2016 | B2 |
9370664 | Marnfeldt et al. | Jun 2016 | B2 |
9375582 | Kaula et al. | Jun 2016 | B2 |
9381360 | Hershey | Jul 2016 | B2 |
9387331 | Zhao et al. | Jul 2016 | B2 |
9387332 | Zhao et al. | Jul 2016 | B2 |
9393423 | Parramon et al. | Jul 2016 | B2 |
9393428 | Nyberg, II et al. | Jul 2016 | B2 |
9393435 | Mashiach | Jul 2016 | B2 |
9398901 | Tischendorf et al. | Jul 2016 | B2 |
9399130 | Bonde et al. | Jul 2016 | B2 |
9399131 | Digiore et al. | Jul 2016 | B2 |
9399143 | Yamamoto et al. | Jul 2016 | B2 |
9403013 | Walker et al. | Aug 2016 | B2 |
9403020 | Wingeier | Aug 2016 | B2 |
9403021 | Dronov | Aug 2016 | B2 |
9407110 | Lui et al. | Aug 2016 | B2 |
9409029 | Perryman et al. | Aug 2016 | B2 |
9435830 | Joshi | Sep 2016 | B2 |
9446251 | Perryman et al. | Sep 2016 | B1 |
9446254 | Ozawa et al. | Sep 2016 | B2 |
9449501 | Grevious et al. | Sep 2016 | B2 |
9452288 | Whitehurst et al. | Sep 2016 | B2 |
9457186 | Gross | Oct 2016 | B2 |
9463321 | Bradley et al. | Oct 2016 | B2 |
9463323 | Lee et al. | Oct 2016 | B2 |
9463326 | Ranu | Oct 2016 | B2 |
9468771 | Griffith et al. | Oct 2016 | B2 |
9468772 | Demmer | Oct 2016 | B2 |
9469437 | Kamath | Oct 2016 | B2 |
9474905 | Doan et al. | Oct 2016 | B2 |
9480841 | Hershey et al. | Nov 2016 | B2 |
9504832 | Libbus et al. | Nov 2016 | B2 |
9504838 | Rao et al. | Nov 2016 | B2 |
9511238 | Mashiach | Dec 2016 | B2 |
9517344 | Bradley | Dec 2016 | B1 |
9517352 | Kast et al. | Dec 2016 | B2 |
9522270 | Perryman et al. | Dec 2016 | B2 |
9526906 | Mashiach | Dec 2016 | B2 |
9533148 | Carcieri | Jan 2017 | B2 |
9533153 | Libbus et al. | Jan 2017 | B2 |
9533154 | Kothandaraman et al. | Jan 2017 | B2 |
9533162 | Ter-petrosyan et al. | Jan 2017 | B2 |
9555257 | Mashiach et al. | Jan 2017 | B2 |
9561365 | Shi et al. | Feb 2017 | B2 |
9585642 | Dinsmoor et al. | Mar 2017 | B2 |
9586054 | Aghassian | Mar 2017 | B2 |
9592385 | Kaula et al. | Mar 2017 | B2 |
9597516 | Lee et al. | Mar 2017 | B2 |
9597517 | Moffitt | Mar 2017 | B2 |
9597521 | Plotkin et al. | Mar 2017 | B2 |
9610450 | Zhao | Apr 2017 | B2 |
9616230 | Grandhe | Apr 2017 | B2 |
9623244 | Kothandaraman | Apr 2017 | B2 |
9623245 | King et al. | Apr 2017 | B2 |
9623253 | Perryman et al. | Apr 2017 | B2 |
9623257 | Olson et al. | Apr 2017 | B2 |
9630231 | Kelsch et al. | Apr 2017 | B2 |
9636508 | Chen et al. | May 2017 | B2 |
9643022 | Mashiach et al. | May 2017 | B2 |
9649049 | Pless et al. | May 2017 | B2 |
9649493 | Mashiach | May 2017 | B2 |
9653941 | Dinsmoor et al. | May 2017 | B2 |
9656074 | Simon et al. | May 2017 | B2 |
9656076 | Trier et al. | May 2017 | B2 |
9656081 | Feldman et al. | May 2017 | B2 |
9675809 | Chow | Jun 2017 | B2 |
9687649 | Thacker | Jun 2017 | B2 |
9700725 | Zhu | Jul 2017 | B2 |
9700730 | Carbunaru et al. | Jul 2017 | B2 |
9707404 | Rao et al. | Jul 2017 | B2 |
9713707 | Oron et al. | Jul 2017 | B2 |
9713717 | Aghassian | Jul 2017 | B2 |
9713718 | Lamont et al. | Jul 2017 | B2 |
9713721 | Kothandaraman | Jul 2017 | B2 |
9724513 | Lane et al. | Aug 2017 | B2 |
9731116 | Chen | Aug 2017 | B2 |
9737703 | Carbunaru et al. | Aug 2017 | B2 |
9737714 | Zottola | Aug 2017 | B2 |
9744347 | Chen et al. | Aug 2017 | B2 |
9744362 | Steinke et al. | Aug 2017 | B2 |
9744365 | Davis et al. | Aug 2017 | B2 |
9744368 | Dinsmoor | Aug 2017 | B2 |
9750930 | Chen | Sep 2017 | B2 |
9782588 | Shi et al. | Oct 2017 | B2 |
9782593 | Parramon et al. | Oct 2017 | B2 |
9782596 | Vamos et al. | Oct 2017 | B2 |
9789314 | Perryman et al. | Oct 2017 | B2 |
9789321 | Dixit et al. | Oct 2017 | B2 |
9789324 | Bauhahn et al. | Oct 2017 | B2 |
9802038 | Lee et al. | Oct 2017 | B2 |
9802048 | Armstrong | Oct 2017 | B2 |
9802052 | Marnfeldt | Oct 2017 | B2 |
9814458 | North | Nov 2017 | B2 |
9814880 | Hershey et al. | Nov 2017 | B2 |
9814884 | Parker et al. | Nov 2017 | B2 |
9839786 | Rondoni et al. | Dec 2017 | B2 |
9844677 | Aghassian | Dec 2017 | B2 |
9849298 | Ozawa et al. | Dec 2017 | B2 |
9855032 | Mashiach et al. | Jan 2018 | B2 |
9855436 | Dearden et al. | Jan 2018 | B2 |
9861825 | Ozawa et al. | Jan 2018 | B2 |
9867989 | Blum et al. | Jan 2018 | B2 |
9867994 | Parramon | Jan 2018 | B2 |
9878158 | Hershey et al. | Jan 2018 | B2 |
9907967 | Mashiach et al. | Mar 2018 | B2 |
9913980 | Ostroff et al. | Mar 2018 | B2 |
9913983 | Gustafsson et al. | Mar 2018 | B2 |
9913986 | Chow et al. | Mar 2018 | B2 |
9913990 | Ter-petrosyan et al. | Mar 2018 | B2 |
9925381 | Nassif | Mar 2018 | B2 |
9929584 | Aghassian et al. | Mar 2018 | B2 |
9931107 | Tischendorf et al. | Apr 2018 | B2 |
9935498 | Joshi | Apr 2018 | B2 |
9943685 | Ramesh et al. | Apr 2018 | B2 |
9950166 | Mashiach et al. | Apr 2018 | B2 |
9950173 | Doan | Apr 2018 | B2 |
9950179 | Bonde et al. | Apr 2018 | B2 |
9956419 | Bokil | May 2018 | B2 |
9956421 | Bunyan et al. | May 2018 | B2 |
9974965 | Perryman et al. | May 2018 | B2 |
9981130 | Lee | May 2018 | B2 |
9993645 | Walker et al. | Jun 2018 | B2 |
10010717 | Aghassian et al. | Jul 2018 | B2 |
10014571 | Andersen et al. | Jul 2018 | B2 |
10052097 | Mashiach et al. | Aug 2018 | B2 |
10056688 | Andersen et al. | Aug 2018 | B2 |
10058705 | Andersen et al. | Aug 2018 | B2 |
10064288 | Li et al. | Aug 2018 | B2 |
10080902 | Dinsmoor et al. | Sep 2018 | B2 |
10105540 | Oron et al. | Oct 2018 | B2 |
10105542 | Jiang et al. | Oct 2018 | B2 |
10105543 | Marnfeldt et al. | Oct 2018 | B2 |
10118040 | Zhu | Nov 2018 | B2 |
10143845 | Kothandaraman | Dec 2018 | B2 |
10149976 | Andresen et al. | Dec 2018 | B1 |
10173062 | Parker | Jan 2019 | B2 |
10177609 | Olson et al. | Jan 2019 | B2 |
10179241 | Walker et al. | Jan 2019 | B2 |
10182807 | Bridgeman et al. | Jan 2019 | B2 |
10195425 | Ostroff et al. | Feb 2019 | B2 |
10213608 | Moffitt | Feb 2019 | B2 |
10219229 | Mulligan, IV | Feb 2019 | B1 |
10226637 | Aghassian et al. | Mar 2019 | B2 |
10532208 | Ostroff et al. | Jan 2020 | B2 |
10583284 | Peters et al. | Mar 2020 | B2 |
11083903 | Nassif et al. | Aug 2021 | B2 |
20020077554 | Schwartz et al. | Jun 2002 | A1 |
20020099419 | Cohen et al. | Jul 2002 | A1 |
20020124848 | Sullivan et al. | Sep 2002 | A1 |
20020183805 | Fang et al. | Dec 2002 | A1 |
20020183817 | Van Venrooij et al. | Dec 2002 | A1 |
20030014016 | Purdy | Jan 2003 | A1 |
20030040774 | Terry et al. | Feb 2003 | A1 |
20030060858 | Kieval et al. | Mar 2003 | A1 |
20030100933 | Ayal | May 2003 | A1 |
20030176898 | Gross et al. | Sep 2003 | A1 |
20030236557 | Whitehurst et al. | Dec 2003 | A1 |
20030236558 | Whitehurst et al. | Dec 2003 | A1 |
20040015205 | Whitehurst et al. | Jan 2004 | A1 |
20040019368 | Lattner et al. | Jan 2004 | A1 |
20040048795 | Ivanova et al. | Mar 2004 | A1 |
20040073270 | Firlik et al. | Apr 2004 | A1 |
20040254624 | Johnson | Jun 2004 | A1 |
20040167584 | Carroll et al. | Aug 2004 | A1 |
20040249431 | Ransbury et al. | Dec 2004 | A1 |
20040254612 | Ezra et al. | Dec 2004 | A1 |
20050119716 | McClure | Jun 2005 | A1 |
20050131495 | Parramon et al. | Jun 2005 | A1 |
20050143789 | Whitehurst | Jun 2005 | A1 |
20050165457 | Benser et al. | Jul 2005 | A1 |
20050182457 | Thrope et al. | Aug 2005 | A1 |
20050251061 | Schuler et al. | Nov 2005 | A1 |
20060020305 | Desai et al. | Jan 2006 | A1 |
20060047327 | Colvin et al. | Mar 2006 | A1 |
20060085039 | Hastings et al. | Apr 2006 | A1 |
20060100668 | Ben-David et al. | May 2006 | A1 |
20060155345 | Williams et al. | Jul 2006 | A1 |
20060271137 | Stanton-Hicks | Nov 2006 | A1 |
20070032827 | Katims | Feb 2007 | A1 |
20070067000 | Strother et al. | Mar 2007 | A1 |
20070067007 | Schulman | Mar 2007 | A1 |
20070073353 | Rooney et al. | Mar 2007 | A1 |
20070073354 | Knudson et al. | Mar 2007 | A1 |
20070083240 | Peterson et al. | Apr 2007 | A1 |
20070088397 | Jacobson | Apr 2007 | A1 |
20070173893 | Pitts | Jul 2007 | A1 |
20070208392 | Kuschner et al. | Sep 2007 | A1 |
20070255349 | Torgerson et al. | Nov 2007 | A1 |
20070293908 | Cowan et al. | Dec 2007 | A1 |
20070293912 | Cowan et al. | Dec 2007 | A1 |
20080004535 | Smits | Jan 2008 | A1 |
20080009914 | Buysman et al. | Jan 2008 | A1 |
20080021336 | Dobak | Jan 2008 | A1 |
20080027513 | Carbunaru | Jan 2008 | A1 |
20080039915 | Van Den Biggelaar | Feb 2008 | A1 |
20080065182 | Strother et al. | Mar 2008 | A1 |
20080071178 | Greenland et al. | Mar 2008 | A1 |
20080091255 | Caparso et al. | Apr 2008 | A1 |
20080103407 | Bolea et al. | May 2008 | A1 |
20080103572 | Gerber | May 2008 | A1 |
20080109054 | Hastings et al. | May 2008 | A1 |
20080119911 | Rosero | May 2008 | A1 |
20080132964 | Cohen et al. | Jun 2008 | A1 |
20080183235 | Stancer et al. | Jul 2008 | A1 |
20080269740 | Bonde et al. | Oct 2008 | A1 |
20090012590 | Inman et al. | Jan 2009 | A1 |
20090036975 | Ward et al. | Feb 2009 | A1 |
20090048642 | Goroszeniuk | Feb 2009 | A1 |
20090149912 | Dacey et al. | Jun 2009 | A1 |
20090152954 | Le et al. | Jun 2009 | A1 |
20090182402 | Glukhovsky | Jul 2009 | A1 |
20090204170 | Hastings et al. | Aug 2009 | A1 |
20090204173 | Fang et al. | Aug 2009 | A1 |
20090234407 | Hastings et al. | Sep 2009 | A1 |
20090259280 | Wilkin et al. | Oct 2009 | A1 |
20090270951 | Kallmyer | Oct 2009 | A1 |
20090281594 | King et al. | Nov 2009 | A1 |
20090326602 | Glukhovsky et al. | Dec 2009 | A1 |
20100069992 | Aghassian et al. | Mar 2010 | A1 |
20100094367 | Sen | Apr 2010 | A1 |
20100121405 | Ternes et al. | May 2010 | A1 |
20100125310 | Wilson et al. | May 2010 | A1 |
20100125313 | Lee et al. | May 2010 | A1 |
20100198298 | Glukovsky et al. | Aug 2010 | A1 |
20100211131 | Williams et al. | Aug 2010 | A1 |
20100241195 | Meadows et al. | Sep 2010 | A1 |
20100244580 | Uchida et al. | Sep 2010 | A1 |
20100249875 | Kishawi et al. | Sep 2010 | A1 |
20100312320 | Faltys et al. | Sep 2010 | A1 |
20100280568 | Bulkes et al. | Nov 2010 | A1 |
20100305392 | Gross et al. | Dec 2010 | A1 |
20100324630 | Lee et al. | Dec 2010 | A1 |
20110034782 | Sugimachi et al. | Feb 2011 | A1 |
20110046696 | Barolat et al. | Feb 2011 | A1 |
20110087337 | Forsell | Apr 2011 | A1 |
20110093036 | Mashiach | Apr 2011 | A1 |
20110112605 | Fahey | May 2011 | A1 |
20110137365 | Ben-Erza et al. | Jun 2011 | A1 |
20110152965 | Mashiach | Jun 2011 | A1 |
20110160792 | Fishel | Jun 2011 | A1 |
20110160793 | Gindele | Jun 2011 | A1 |
20110160798 | Ackermann et al. | Jun 2011 | A1 |
20110208260 | Jacobson | Aug 2011 | A1 |
20110208271 | Dobak | Aug 2011 | A1 |
20110224744 | Moffitt et al. | Sep 2011 | A1 |
20110224769 | Spenser et al. | Sep 2011 | A1 |
20110230922 | Fishel | Sep 2011 | A1 |
20110270339 | Murray et al. | Nov 2011 | A1 |
20110282412 | Glukhovsky et al. | Nov 2011 | A1 |
20110301662 | Bar-Yoseph et al. | Dec 2011 | A1 |
20110301670 | Gross | Dec 2011 | A1 |
20120004709 | Chen et al. | Jan 2012 | A1 |
20120010694 | Lutter et al. | Jan 2012 | A1 |
20120035679 | Dagan et al. | Feb 2012 | A1 |
20120041511 | Lee | Feb 2012 | A1 |
20120041514 | Gross et al. | Feb 2012 | A1 |
20120065701 | Cauller | Mar 2012 | A1 |
20120083857 | Bradley et al. | Apr 2012 | A1 |
20120101326 | Simon et al. | Apr 2012 | A1 |
20120123498 | Gross | May 2012 | A1 |
20120130448 | Woods et al. | May 2012 | A1 |
20120130463 | Ben-David et al. | May 2012 | A1 |
20120158081 | Gross et al. | Jun 2012 | A1 |
20120215285 | Tahmasian et al. | Aug 2012 | A1 |
20120256494 | Kesler | Oct 2012 | A1 |
20120296389 | Fang et al. | Nov 2012 | A1 |
20130006326 | Ackermann et al. | Jan 2013 | A1 |
20130066393 | Gross et al. | Mar 2013 | A1 |
20130192611 | Taepke, II et al. | Aug 2013 | A1 |
20130289662 | Olson | Oct 2013 | A1 |
20130325084 | Lee | Dec 2013 | A1 |
20140031840 | Mashiach | Jan 2014 | A1 |
20140031903 | Mashiach | Jan 2014 | A1 |
20140184150 | Walley | Jul 2014 | A1 |
20140214134 | Peterson | Jul 2014 | A1 |
20140296940 | Gross | Oct 2014 | A1 |
20150004709 | Nazarpoor | Jan 2015 | A1 |
20150018598 | Nabutovsky et al. | Jan 2015 | A1 |
20150018728 | Gross et al. | Jan 2015 | A1 |
20150039046 | Gross | Feb 2015 | A1 |
20150080979 | Lasko et al. | Mar 2015 | A1 |
20150100109 | Feldman et al. | Apr 2015 | A1 |
20150148861 | Gross | May 2015 | A1 |
20150148878 | Yoo et al. | May 2015 | A1 |
20150174406 | Lamensdorf et al. | Jun 2015 | A1 |
20150202449 | Chen | Jul 2015 | A1 |
20150258339 | Burchiel et al. | Sep 2015 | A1 |
20150270719 | Kurs | Sep 2015 | A1 |
20150335882 | Gross et al. | Nov 2015 | A1 |
20160206882 | Oron et al. | Jul 2016 | A1 |
20160206889 | Plotkin et al. | Jul 2016 | A1 |
20160206890 | Oron et al. | Jul 2016 | A1 |
20160294366 | Bao | Oct 2016 | A1 |
20160361544 | Oron et al. | Dec 2016 | A1 |
20170007829 | Gross | Jan 2017 | A1 |
20170128724 | Oron et al. | May 2017 | A1 |
20170136232 | Oron et al. | May 2017 | A1 |
20170224996 | Oron et al. | Aug 2017 | A1 |
20170232255 | Kent et al. | Aug 2017 | A1 |
20170296426 | Oron et al. | Oct 2017 | A1 |
20180353764 | Oron et al. | Dec 2018 | A1 |
20200046974 | Ostroff et al. | Feb 2020 | A1 |
Number | Date | Country |
---|---|---|
102008054403 | Jun 2010 | DE |
0 688 577 | Dec 1995 | EP |
1533000 | May 2005 | EP |
1703638 | Nov 2012 | EP |
1998010832 | Mar 1998 | WO |
1999026530 | Jun 1999 | WO |
0110432 | Feb 2001 | WO |
2001010375 | Feb 2001 | WO |
0126729 | Apr 2001 | WO |
0209808 | Feb 2002 | WO |
2004064729 | Aug 2004 | WO |
2006102626 | Sep 2006 | WO |
2007019491 | Feb 2007 | WO |
2009055574 | Apr 2009 | WO |
2009110935 | Sep 2009 | WO |
2011154937 | Dec 2011 | WO |
2012012591 | Jan 2012 | WO |
2013035092 | Mar 2013 | WO |
2013106884 | Jul 2013 | WO |
2013111137 | Aug 2013 | WO |
2013156038 | Oct 2013 | WO |
2013164829 | Nov 2013 | WO |
2014081978 | May 2014 | WO |
2014087337 | Jun 2014 | WO |
2014167568 | Oct 2014 | WO |
2015004673 | Jan 2015 | WO |
2016028608 | Feb 2016 | WO |
2016157183 | Oct 2016 | WO |
2016172109 | Oct 2016 | WO |
Entry |
---|
Raab, Frederick. “Idealized operation of the class E tuned power amplifier.” IEEE transactions on Circuits and Systems 24.12 (1977): 725-735. |
An Office Action dated Jun. 17, 2021, which issued during the prosecution of U.S. Appl. No. 16/363,256. |
An Office Action dated Dec. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/581,390. |
An Office Action dated Jun. 26, 2019, which issued during the prosecution of U.S. Appl. No. 15/395,257. |
An Office Action dated Feb. 7, 2019, which issued during the prosecution of U.S. Appl. No. 15/706,956. |
Alo, Kenneth M., et al. “Lumbar and sacral nerve root stimulation (NRS) in the treatment of chronic pain: a novel anatomic approach and neuro stimulation technique.” Neuromudulation: Technology at the Neural Interface 2.1 (1999): 23-31. |
Gofeld, Michael, and John G. Hanlon. “Ultrasound-Guided Placement of a Paddle Lead Onto Peripheral Nerves: Surgical Anatomy and Methodology.” Neuromodulation: Technology at the Neural Interface 17.1 (2014): 48-53. |
Stuart, R. Morgan, and Christopher J. Winfree. “Neurostimulation techniques for painful peripheral nerve disorders.” Neurosurgery Clinics of North America 20.1 (2009): 111-120. |
An Office Action dated Dec. 21, 2020, which issued during the prosecution of U.S. Appl. No. 16/363,256. |
An Office Action dated Dec. 2, 2020, which issued during the prosecution of U.S. Appl. No. 16/166,383. |
C. de Balthasar, G. Cosendai, M. Hansen, D. Canfield, L. Chu, R. Davis, and J. Schulman, “Attachment of leads to RF-BION® microstimulators.” Jul. 2005. |
D.W. Eisele, A.R. Schwartz, and P.L. Smith, “Tongue neuromuscular and direct hypoglossal nerve stimulation for obstructive sleep apnea.,” Otolaryngologic clinics of North America, vol. 36, 2003, p. 501. |
G.E. Loeb, F.J.R. Richmond, J. Singh, R.A. Peck, W. Tan, Q. Zou, and N. Sachs, “RF-powered BIONs™ for stimulation and sensing,” Engineering in Medicine and Biology Society, 2004. IEMBS'04. 26th Annual International Conference of the IEEE, 2005, pp. 4182-4185. |
G.E. Loeb, F.J. Richmond, and L.L. Baker, “The BION devices: injectable interfaces with peripheral nerves and muscles,” Neurosurgical focus, vol. 20, 2006, pp. 1-9. |
E.A. Mann, T. Burnett, S. Cornell, and C.L. Ludlow, “The effect of neuromuscular stimulation of the genioglossus on the hypopharyngeal airway,” The Laryngoscope, vol. 112, 2002, pp. 351-356. |
A. Oliven, R.P. Schnall, G. Pillar, N. Gavriely, and M. Odeh, “Sublingual electrical stimulation of the tongue during wakefulness and sleep,” Respiration physiology, vol. 127, 2001, pp. 217-226. |
A. Oliven, D.J. O'Hearn, A. Boudewyns, M. Odeh, W. De Backer, P. van de Heyning, P.L. Smith, D.W. Eisele, L. Allan, H. Schneider, and others, “Upper airway response to electrical stimulation of the genioglossus in obstructive sleep apnea,” Journal of Applied Physiology, vol. 95, 2003, p. 2023. |
A. Oliven, M. Odeh, L. Geitini, R. Oliven, U. Steinfeld, A.R. Schwartz, and N. Tov, “Effect of coactivation of tongue protrusor and retractor muscles on pharyngeal lumen and airflow in sleep apnea patients,” Journal of Applied Physiology, vol. 103, 2007, p. 1662. |
A.R. Schwartz, D.W. Eisele, A. Hari, R. Testerman, D. Erickson, and P.L. Smith, “Electrical stimulation of the lingual musculature in obstructive sleep apnea,” Journal of Applied Physiology, vol. 81, 1996, p. 643. |
W.H. Tran, G.E. Loeb, F.J.R. Richmond, A.C. Dupont, K.C. Mahutte, C.S.H. Sassoon, and M.J. Dickel, “Development of asynchronous, intralingual electrical stimulation to treat obstructive sleep apnea,” Engineering in Medicine and Biology Society, 2003. Proceedings of the 25th Annual International Conference of the IEEE, 2004, pp. 375-378. |
W.H. Tran, G.E. Loeb, F.J.R. Richmond, R. Ahmed, G.T. Clark, and P.B. Haberman, “First subject evaluated with simulated BION™ treatment in genioglossus to prevent obstructive sleep apnea,” Engineering in Medicine and Biology Society, 2004. IEMBS'04. 26th Annual International Conference of the IEEE, 2005, pp. 4287-4289. |
P.R. Troyk, “Injectable electronic identification, monitoring, and stimulation systems,” Biomedical Engineering, vol. 1, 1999, p. 177. |
T.K. Whitehurst, J.H. Schulman, K.N. Jaax, and R. Carbunaru, “The Bion® Microstimulator and its Clinical Applications,” Implantable Neural Prostheses 1, 2009, pp. 253-273. |
D.J. Young, “Wireless powering and data telemetry for biomedical implants,” Engineering in Medicine and Biology Society, 2009. EMBC 2009. Annual International Conference of the IEEE, 2009, pp. 3221-3224. |
Reid R. Harrison, et al., “Wireless Neural Recording with Single Low-Power Integrated Circuit”, IEEE Trans Neural Syst Rehabil Eng. Aug. 2009; 17(4): 322-329. |
An International Search Report and a Written Opinion both dated Apr. 17, 2012 which issued during the prosecution of Applicant's PCT/IL11/00870. |
Patents Galore: Implantable Neurostimulators Fight Snoring and Corpse Eye-Proof Scanners. Printout from http://medgadget.com/2006/03/patents_galore.html (Downloaded Jan. 2012). |
Chris Seper, “Neuros Medical Launches to Develop New Device to Block Amputee, Chronic Pain”, Mar. 17, 2009. |
Urgent® PC, Simple. Safe. Effective. Neuromodulation System, Uroplasty, Mar. 2009. |
“JumpStart and Case Technology Ventures Invest in Neuros Medical”, CTV Case Technology Ventures, Mar. 17, 2009. |
“Responses to median and tibial nerve stimulation in patients with chronic neuropathic pain”, by Theuvenet, Brain Topography, vol. 11, No. 4, 1999, pp. 305-313(9)—an abstract. |
Armstrong, J, “Is electrical stimulation effective in reducing neuropathic pain in patients with diabetes?”, by Foot Ankle Surg. Jul.-Aug. 1997; 36(4): 260-3—an abstract. |
Ross Davis, Cerebellar Stimulation for Cerebral Palsy Spasticity, Function and Seizures. Clinical Neuroscience Center, 1999. pp. 290-299. |
An Office Action dated Feb. 13, 2004, which issued during the prosecution of U.S. Appl. No. 10/254,024. |
Bathien et al., Inhibition and synchronisation of tremor induced by a muscle twitch. J. Neurol, Neurosurg. and Psych. 1980, 43, 713-718. |
Jobges et al., Vibratory proprioceptive stimulation affects Parkinsonian tremor. Parkinsonism & Related Disorders, 8(3), 171-176, Jan. 2002. |
Mones and Weiss, The response of the tremor of patients with Parkinsonism to peripheral nerve stimulation. J. Neurol. Neurosurg. Psychiat. 1969, 32. 512-519. |
Y. Zhang, et al., “Optimal Ventricular Rate Slowing During Atrial Fibrillation by Feedback AV Nodal-Selective Vagal Stimulation”, Am J Physiol Heart Circ Physiol 282:H1102-H1110, 2002. |
N.J.M Rijkhoff, et al., “Selective Stimulation of Small Diameter Nerve Fibers in a Mixed Bundle”, Proceedings of the Annual Project Meeting Sensations/Neuros and Mid Term Review Meeting Neuros, Apr. 21-23, 1999. |
M. Manfredi, “Differential Block of conduction of larger fibers in peripheral nerve by direct current”, Arch. Ital. Biol. 108:52-71, 1970. |
A Restriction Requirement dated May 11, 2012, which issued during the prosecution of U.S. Appl. No. 12/946,246. |
Cerebral Palsy, Barry S. Russman MD, CCurrent Science Inc. 2000. |
A Notice of Allowance dated Mar. 7, 2005, which issued during the prosecution of U.S. Appl. No. 10/254,024. |
A Notice of Allowance dated Aug. 26, 2004, which issued during the prosecution of U.S. Appl. No. 10/254,024. |
An Office Action dated Jun. 24, 2011, which issued during the prosecution of U.S. Appl. No. 12/796,102. |
An International Search Report and a Written Opinion both dated Nov. 14, 2011, which issued during the prosecution of Applicant's PCT/IL2011/000440. |
An International Preliminary Report on Patentability dated Dec. 10, 2012, which issued during the prosecution of Applicant's PCT/IL2011/000440. |
U.S. Appl. No. 60/263,834, filed Jan. 2, 2001. |
Sweeney JD et al., “An asymmetric two electrode cuff for generation of unidirectionally propagated action potentials,” IEEE Transactions on Biomedical Engineering, vol. BME-33(6) (1986). |
An Office Action dated Apr. 9, 2012, which issued during the prosecution of U.S. Appl. No. 12/796,102. |
Invitation to pay Additional Fees dated May 10, 2013 which issued during the prosecution of Applicant's PCT/IL2013/050069. |
Naples GG et al., “A spiral nerve cuff electrode for peripheral nerve stimulation,” by IEEE Transactions on Biomedical Engineering, 35(11) (1988). |
Sweeney JD et al., “A nerve cuff technique for selective excitation of peripheral nerve trunk regions,” IEEE Transactions on Biomedical Engineering, 37(7) (1990). |
Ungar IJ et al., “Generation of unidirectionally propagating action potentials using a monopolar electrode cuff,” Annals of Biomedical Engineering, 14:437-450 (1986). |
Fitzpatrick et al., in “A nerve cuff design for the selective activation and blocking of myelinated nerve fibers,” Ann. Conf. of the IEEE Eng. in Medicine and Biology Soc, 13(2), 906 (1991). |
Rijkhoff NJ et al., “Orderly recruitment of motoneurons in an acute rabbit model,” Ann. Conf. of the IEEE Eng., Medicine and Biology Soc., 20(5):2564 (1998). |
Van den Honert C et al., “A technique for collision block of peripheral nerve: Frequency dependence,” MP-12, IEEE Trans. Biomed. Eng. 28:379-382 (1981). |
Baratta R et al., “Orderly stimulation of skeletal muscle motor units with tripolar nerve cuff electrode,” IEEE Transactions on Biomedical Engineering, 36(8):836-43 (1989). |
Van den Honert C et al., “Generation of unidirectionally propagated action potentials in a peripheral nerve by brief stimuli,” Science, 206:1311-1312 (1979). |
M. Devor, “Pain Networks”, Handbook of Brand Theory and Neural Networks, ED M.A. Arbib MIT Press pp. 696-701, 1998. |
Epilepsy center. http://www.bcm.tmc.edu/neural/struct/epilep/epilpsy_vagus.html. |
J.F. Cortese, “Vagus Nerve Stimulation for Control of Intractable Epileptic Seizures”, May 31, 2001. |
Evetovich T.K. et al., Gender comparisons of the mechanomyographic responses to minimal concentric and eccentric isokinetic muscle actions, Medicine & Science in Sports & Exercise, 1998 pp. 1697-1702. Abstract. |
An Office Action dated Dec. 5, 2013, which issued during the prosecution of U.S. Appl. No. 13/528,433. |
An Office Action dated Sep. 30, 2013, which issued during the prosecution of U.S. Appl. No. 12/796,102. |
Chow et al., Evaluation of Cardiovascular Stents as Antennas for Implantable Wireless Applications, IEEE Transactions on Microwave Theory and Techniques, vol. 57, No. 10, Oct. 2009. |
Dean, J. et al., “Motor Pattern Generation”, Handbook of Brain Theory and Neural Networks, pp. 696-701. |
Hu et al., Percutaneous Biphasic Electrical Stimulation for Treatment of Obstructive Sleep Apnea Syndrome, IEEE Transactions on Biomedical Engineering, Jan. 2008 vol. 55 lssue:1 p. 181-187—an abstract. |
A. Oliven, Electrical stimulation of the genioglossus to improve pharyngeal patency in obstructive sleep apnea: comparison of resultsobtained during sleep and anesthesia, U.S. National Library of Medicine, National Institutes of Health May 2009;148(5):315-9, 350, 349—an abstract. |
U.S. Appl. No. 61/591,024, filed Jan. 26, 2012. |
Mortimer et al., Peripheral Nerve and Muscle Stimulation, Neuroprosthetics Theory and Practice, Chapter 4.2, 2004, p. 632-638. |
An Office Action dated May 19, 2017, which issued during the prosecution of U.S. Appl. No. 14/935,941. |
Zabara J., Inhibition of experimental seizures in canines by repetitive vagal stimulation, Epilepsia. Nov.-Dec. 1992;33 (6):1005-12, http://www.ncbi.nlm.nih.gov/pubmed/1464256—an abstract. |
A Notice of Allowance dated Jun. 9, 2014, which issued during the prosecution of U.S. Appl. No. 12/796,102. |
Notice of Allowance dated Sep. 1, 2017, which issued during the prosecution of U.S. Appl. No. 14/649,873. |
Brindley (1983) A technique for anodally blocking large nerve fibers. |
An Office Action dated Sep. 22, 2016, which issued during the prosecution of U.S. Appl. No. 14/374,375. |
DJOGlobal.com—Interferential Current Therapy (IFC). |
A Notice of Allowance dated Apr. 25, 2014, which issued during the prosecution of U.S. Appl. No. 13/528,433. |
U.S. Appl. No. 61/662,073, filed Jun. 20, 2012. |
An Office Action dated Sep. 26, 2013, which issued during the prosecution of U.S. Appl. No. 13/528,433. |
U.S. Appl. No. 60/985,353, filed Nov. 5, 2007. |
Notice of Allowance dated Jun. 1, 2017, which issued during the prosecution of U.S. Appl. No. 14/601,626. |
electrotherapy.org—Interferential Therapy. |
Notice of Allowance dated May 17, 2017, which issued during the prosecution of U.S. Appl. No. 14/601,626. |
Lind (2012) Advances in spinal cord stimulation. |
Physical Therapy Web.com—Interferential Current (IFC) Equipment. |
Shealy (1967) Electrical inhibition of pain by stimulation of the dorsal columns. |
Nov. 30, 2015 massdevice.com—St. Jude Medical's Proclaim Elite debuts in Europe. |
Kaplan et al. (2009) Design and fabrication of an injection tool for neuromuscular microstimulators. |
Supplementary European Search Report dated Dec. 22, 2014, which issued during the prosecution of Applicant's European App No. 11792044.7. |
An Office Action dated Oct. 30, 2015, which issued during the prosecution of U.S. Appl. No. 14/226,723. |
Notice of Allowance dated Nov. 4, 2016, which issued during the prosecution of U.S. Appl. No. 14/601,568. |
Sinan Filiz, Luke Xie, Lee E. Weiss, O.B. Ozdoganlar, Micromilling of microbarbs for medical implants, International Journal of Machine Tools and Manufacture, vol. 48, Issues 3-4, Mar. 2008, pp. 459-472. |
UCLA Team Reports Initial Success with Trigeminal Nerve Stimulation epilepsy. https://web.archive.org/web/20121020145122/https:/www.epilepsy.com/epilepsy/newsletter/apr09_STIM. |
Kucklick, Theodore R., ed. The medical device R&D handbook. Chapter 3—Intro to needles and cannulae. CRC Press, 2012. |
Szmurlo, R., Starzynski, J., Wincenciak, S. and Rysz, A. (2009) ‘Numerical model of vagus nerve electrical stimulation’, COMPEL—The international journal for computation and mathematics in electrical and electronic engineering, 28(1), pp. 211-220. |
An Office Action dated Apr. 5, 2017, which issued during the prosecution of U.S. Appl. No. 14/374,375. |
Mitchum, A Shocking Improvement in Cardiology Science Life Blog, University of Chicago, http://sciencelife.uchospitals.edu/2010/04/13/a-shocking-improvement-in-cardiology/ (Downloaded Nov. 3, 2012). |
Reggiani et al. “Biophysical effects of high frequency electrical field on muscle fibers in culture.” (2009) pp. 49-56. |
https://www.uroplasty.com/files/pdf/20158.pdf Brochure (Downloaded Oct. 16, 2014). |
An Office Action dated Aug. 8, 2016, which issued during the prosecution of U.S. Appl. No. 14/735,741. |
An International Search Report and a Written Opinion both dated Jul. 11, 2013, which issued during the prosecution of Applicant's PCT/IL2013/050069. |
An International Search Report and a Written Opinion both dated Apr. 29, 2014, which issued during the prosecution of Applicant's PCT/IB2013/060607. |
An International Preliminary Report on Patentability dated Jul. 29, 2014, which issued during the prosecution of Applicant's PCT/IL2013/050069. |
An International Preliminary Report on Patentability dated Jun. 9, 2015, which issued during the prosecution of Applicant's PCT/IB2013/060607. |
An Office Action dated Dec. 12, 2016, which issued during the prosecution of U.S. Appl. No. 14/939,418. |
Ex Parte Quayle Action dated Sep. 14, 2016, which issued during the prosecution of U.S. Appl. No. 14/601,568. |
An Office Action dated May 13, 2016, which issued during the prosecution of U.S. Appl. No. 14/601,568. |
An Office Action dated Aug. 11, 2016, which issued during the prosecution of U.S. Appl. No. 14/601,626. |
CBS news article entitled, “Migraine ‘smart’ patch tested to help ease pain” by Steven Reinberg. |
Zhang, D., Zhang, Z., Zi, Z., Zhang, Y., Zeng, W. and Chu, P.K., 2008. Fabrication of graded TiN coatings on nitinol occluders and effects on in vivo nickel release. Bio-medical materials and engineering, 18(6), pp. 387-393—an abstract. |
Cardiovascular Stents as Antennas for Implantable Wireless Applications, by Ebrish, BMEN 5151, Apr. 29, 2010. |
An Office Action dated Nov. 21, 2016, which issued during the prosecution of U.S. Appl. No. 14/601,626. |
Spinal Cord Stimulation advanced level (Mayfield clinic)—dated Feb. 2010. |
European Search Report dated Feb. 3, 2017, which issued during the prosecution of Applicant's European App No. 16196878.9. |
Amendment in Response to Official Action dated Jan. 24, 2019 from the United States Patent and Trademark Office in U.S. Appl. No. 15/621,433. |
An Office Action dated Dec. 6, 2017, which issued during the prosecution of U.S. Appl. No. 14/601,604. |
An Office Action dated Dec. 26, 2017, which issued during the prosecution of U.S. Appl. No. 14/935,941. |
An Office Action dated Jan. 8, 2018, which issued during the prosecution of U.S. Appl. No. 14/935,941. |
An Office Action dated Mar. 5, 2018, which issued during the prosecution of U.S. Appl. No. 15/360,501. |
An Office Action dated Nov. 30, 2017, which issued during the prosecution of U.S. Appl. No. 15/726,971. |
Abkenari, Lara Dabiri, et al. “Clinical experience with a novel subcutaneous implantable defibrillator system in a single center.” Clinical Research in Cardiology 100.9 (2011): 737-744. |
St. Jude Medical, Inc. fact sheet entitled, “Peripheral Nerve Stimulation for Intractable Chronic Migraine”. |
Automatic Impedance Matching for 13.56 MHz NFC Antennas In Proceedings of the 6th Symposium on Communication Systems, Networks and Digital Signal Processing (2008) by Michael Roland, Harald Witschnig, Christian Saminger. |
Takahata, K.; DeHennis, A.; Wise, K.D.; Gianchandani, Y.B., “Stentenna: a micromachined antenna stent for wireless monitoring of implantable microsensors,” in Engineering in Medicine and Biology Society, 2003. Proceedings of the 25th Annual International Conference of the IEEE , vol. 4, No., pp. 3360-3363 vol. 4, 17-21. |
Itchkawitz—OC TechInnovation Blog—Electrodes for implantable defibrillator. Printout from http://octechinnovation.com/tag/cameron-health (Downloaded Mar. 2012). |
Kaszala, K. and Ellenbogen, K.A., 2010. Device sensing sensors and algorithms for pacemakers and implantable cardioverter defibrillators. Circulation, 122(13), pp. 1328-1340. |
An Office Action dated Apr. 22, 2019, which issued during the prosecution of U.S. Appl. No. 15/638,924. |
An Office Action dated Oct. 11, 2018, which issued during the prosecution of U.S. Appl. No. 15/638,924. |
Notice of Allowance dated Jan. 17, 2020, which issued during the prosecution of U.S. Appl. No. 15/638,924. |
An Interview Summary dated Mar. 5, 2019, which issued during the prosecution of U.S. Appl. No. 15/638,924. |
An Advisory Action and an Interview Summary dated Sep. 16, 2019, which issued during the prosecution of U.S. Appl. No. 15/638,924. |
An Office Action dated Jan. 24, 2019, which issued during the prosecution of U.S. Appl. No. 15/621,433. |
An Office Action dated Jul. 9, 2019, which issued during the prosecution of U.S. Appl. No. 15/621,433. |
An Office Action dated Oct. 30, 2018, which issued during the prosecution of U.S. Appl. No. 15/621,433. |
Number | Date | Country | |
---|---|---|---|
20220168580 A1 | Jun 2022 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 15621433 | Jun 2017 | US |
Child | 16737253 | US |
Number | Date | Country | |
---|---|---|---|
Parent | 16737253 | Jan 2020 | US |
Child | 17546644 | US |